M
Melanoma Research Alliance
The Melanoma Research Alliance exists to accelerate treatment options and find a cure for melanoma
About Melanoma Research Alliance
The Melanoma Research Alliance (MRA) is a public charity committed to advancing the fight against melanoma.
Read full description
As the largest non-profit funder of melanoma research globally, MRA's primary activity is providing grants for scientific investigation. The organization has invested over $150 million, supporting more than 440 grant awards. Its funding strategy is comprehensive, covering a wide spectrum of research areas, including prevention, diagnosis, and treatment of melanoma.
MRA operates on a collaborative model, forming partnerships with individuals, private foundations, and corporations to amplify its impact. These collaborations are crucial for funding a diverse portfolio of research projects, from individual investigator-led studies to large-scale, multi-institutional team science projects.
In addition to research funding, the organization provides a range of support resources for patients and their families. This includes the Melanoma > Exchange, an online community platform where individuals affected by melanoma can connect, share experiences, and find support. MRA also offers educational materials and resources to help patients navigate their diagnosis and treatment options.
At a glance
- Status
- Operational
- Founded
- 2007
- Headquarters
- United States
- Employees
- 22
- Open positions
- 3
- Dealroom signal
- 63.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Charity, Biotechnology, Oncology, Patient Engagement, Immune System, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Melanoma Research Alliance.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCEquity / VC | Nov 2019 | $20M | $80M | Undisclosed | — |
| LATE VC✓Equity / VC | Nov 2017 | $20M | $80M | Undisclosed | — |
Growth signals
Latest recorded traffic for Melanoma Research Alliance is 57K monthly website visits, up 9.6% over the last three months. Melanoma Research Alliance's team declined 8.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Melanoma Research Alliance on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Melanoma Research Alliance’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.